Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Prolonged IKKβ Inhibition Improves Ongoing CTL Antitumor Responses by Incapacitating Regulatory T Cells.

Heuser C, Gotot J, Piotrowski EC, Philipp MS, Courrèges CJF, Otte MS, Guo L, Schmid-Burgk JL, Hornung V, Heine A, Knolle PA, Garbi N, Serfling E, Evaristo C, Thaiss F, Kurts C.

Cell Rep. 2017 Oct 17;21(3):578-586. doi: 10.1016/j.celrep.2017.09.082.

2.

Cutting Edge: Engineering Active IKKβ in T Cells Drives Tumor Rejection.

Evaristo C, Spranger S, Barnes SE, Miller ML, Molinero LL, Locke FL, Gajewski TF, Alegre ML.

J Immunol. 2016 Apr 1;196(7):2933-8. doi: 10.4049/jimmunol.1501144. Epub 2016 Feb 22.

3.

Analysis of GzmbCre as a Model System for Gene Deletion in the Natural Killer Cell Lineage.

Xu Y, Evaristo C, Alegre ML, Gurbuxani S, Kee BL.

PLoS One. 2015 Apr 29;10(4):e0125211. doi: 10.1371/journal.pone.0125211. eCollection 2015.

4.

T cell-NF-κB activation is required for tumor control in vivo.

Barnes SE, Wang Y, Chen L, Molinero LL, Gajewski TF, Evaristo C, Alegre ML.

J Immunother Cancer. 2015 Jan 20;3(1):1. doi: 10.1186/s40425-014-0045-x. eCollection 2015.

5.

Basal NF-κB controls IL-7 responsiveness of quiescent naïve T cells.

Miller ML, Mashayekhi M, Chen L, Zhou P, Liu X, Michelotti M, Tramontini Gunn N, Powers S, Zhu X, Evaristo C, Alegre ML, Molinero LL.

Proc Natl Acad Sci U S A. 2014 May 20;111(20):7397-402. doi: 10.1073/pnas.1315398111. Epub 2014 May 5.

6.

Cognate antigen stimulation generates potent CD8(+) inflammatory effector T cells.

Sung HC, Lemos S, Ribeiro-Santos P, Kozyrytska K, Vasseur F, Legrand A, Charbit A, Rocha B, Evaristo C.

Front Immunol. 2013 Dec 16;4:452. doi: 10.3389/fimmu.2013.00452. eCollection 2013.

7.

IFN-γ: The Dr. Jekyll and Mr. Hyde of immunology?

Evaristo C, Alegre ML.

Am J Transplant. 2013 Dec;13(12):3057-8. doi: 10.1111/ajt.12468. Epub 2013 Oct 22. No abstract available.

8.

Cell-to-cell interactions and signals involved in the reconstitution of peripheral CD8 T(CM) and T(EM) cell pools.

Zaragoza B, Evaristo C, Kissenpfennig A, Libri V, Malissen B, Rocha B, Freitas AA, Almeida AR.

PLoS One. 2011 Mar 14;6(3):e17423. doi: 10.1371/journal.pone.0017423.

9.

High TCR stimuli prevent induced regulatory T cell differentiation in a NF-κB-dependent manner.

Molinero LL, Miller ML, Evaristo C, Alegre ML.

J Immunol. 2011 Apr 15;186(8):4609-17. doi: 10.4049/jimmunol.1002361. Epub 2011 Mar 16.

10.

Transcriptional regulation during CD8 T-cell immune responses.

Munitic I, Evaristo C, Sung HC, Rocha B.

Adv Exp Med Biol. 2010;684:11-27.

PMID:
20795537
11.

Epitope specificity and relative clonal abundance do not affect CD8 differentiation patterns during lymphocytic choriomeningitis virus infection.

Munitic I, Decaluwe H, Evaristo C, Lemos S, Wlodarczyk M, Worth A, Le Bon A, Selin LK, Rivière Y, Di Santo JP, Borrow P, Rocha B.

J Virol. 2009 Nov;83(22):11795-807. doi: 10.1128/JVI.01402-09. Epub 2009 Sep 2.

12.

CD8 single-cell gene coexpression reveals three different effector types present at distinct phases of the immune response.

Peixoto A, Evaristo C, Munitic I, Monteiro M, Charbit A, Rocha B, Veiga-Fernandes H.

J Exp Med. 2007 May 14;204(5):1193-205. Epub 2007 May 7.

13.

Cartography of gene expression in CD8 single cells: novel CCR7- subsets suggest differentiation independent of CD45RA expression.

Monteiro M, Evaristo C, Legrand A, Nicoletti A, Rocha B.

Blood. 2007 Apr 1;109(7):2863-70.

PMID:
17148588
14.

In vivo selective and distant killing of cancer cells using adenovirus-mediated decorin gene transfer.

Tralhão JG, Schaefer L, Micegova M, Evaristo C, Schönherr E, Kayal S, Veiga-Fernandes H, Danel C, Iozzo RV, Kresse H, Lemarchand P.

FASEB J. 2003 Mar;17(3):464-6. Epub 2003 Jan 21.

Supplemental Content

Loading ...
Support Center